Content of review 1, reviewed on February 26, 2023

I thank the authors for working so hard in the revised version of the manuscript and addressing in detail all previous comments. The data are highly interesting and may open many future projects aimed to investigate the relevance of CCNI in cancer. I recommend publication of this very interesting work.

Source

    © 2023 the Reviewer.

References

    Eva, Q., Nuria, M., Sara, H., Abril, S., Laura, G., Ainhoa, F., Sara, P., Marc, M. J., Samuel, B., M., M. P., Martin, F., Jordi, V., C., M. M., August, V., Alberto, V., Josep, C., C., R. M. P. 2023. CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation. Molecular Oncology.